Tenderwize
Retour à la recherche

Supply of Medicinal Products - Nivolumab

Centrum Onkologii im. Franciszka Łukaszczyka w Bydgoszczy·Bydgoszcz, Poland·Expired · Jul 31, 2026·Open·Supplies
Structured notice only
Titre original de l'avis

Poland – Antineoplastic agents – Dostawa produktów leczniczych- Nivolumabum

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesExpired
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

20 / 100

Facteurs de risque

Estimated value is absent, hindering assessment of project size and financial viability.

Reverse procedure (evaluation before qualification) may lead to wasted effort if the highest bidder fails qualification.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
Centrum Onkologii im. Franciszka Łukaszczyka w Bydgoszczy
Pays
Pologne
CPV
33652100 - Antineoplastic agents
Date limite
Jul 31, 2026

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration 12 MONTH
  • Supply of Nivolumab (antineoplastic agent) to the contracting authority's hospital in Bydgoszcz.
  • Contract duration of 12 months.
Afficher le résumé complet

Supply of antineoplastic agent Nivolumab to the Oncology Center in Bydgoszcz, Poland. Open procedure with single lot, 100% price award criterion. No estimated value provided. Requires authorization to trade pharmaceutical products. Potential reverse procedure (evaluation before qualification). EU funding flag present but conflicts with XML notice.

Risques

Estimated value is absent, hindering assessment of project size and financial viability.

Reverse procedure (evaluation before qualification) may lead to wasted effort if the highest bidder fails qualification.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Bidders must hold authorization to trade pharmaceutical products.

Administrative

  • Electronic submission is required via the platform Ouvrir le portail
  • Tenders must be submitted in Polish language.

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Price 100% (per-exa) — 100%

Acheteur

Localisation

Bydgoszcz, POL

Identifiant

5542217419

Activité

Health

Lots (1)

LOT-0001

Supply of Medicinal Products - Nivolumab

Supply of Nivolumab for a 12-month period to Centrum Onkologii im. Franciszka Łukaszczyka w Bydgoszczy. Single lot, 100% price criterion. Requires authorization for pharmaceutical trading.

SuppliesEU fundedElectronic submissionSME suitable

Localisation

Bydgoszcz, Poland

Durée

12 MONTH

Catégorie

Antineoplastic agents

Critères d'attribution

Price

Date limite

Expired Jul 31, 2026

Détails de la procédure

Date de publication
30 Jun 2026
Langues
Polish

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
452486-2026

Documents (1)